Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions
Hydroxychloroquine Toxic Retinopathy
Interventions
DIAGNOSTIC_TEST

visual field testing (10-2), spectral domain ocular coherence tomography and Fundus auto-fluorescence

The diagnosis of toxic retinopathy was based on the positivity of at least two objective tests to confirm the subjective findings. The presence or absence of toxicity was recorded.

Trial Locations (1)

11534

The Eye Center, Riyadh

All Listed Sponsors
collaborator

King Khalid University Hospital

OTHER

lead

The Eye Center and The Eye Foundation for Research in Ophthalmology

OTHER

NCT04010110 - Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics | Biotech Hunter | Biotech Hunter